Maykl C. Snabes, MD, PhD, vice president of the clinical maturation of the Pharmaceuticalses BioSante, will present the review of the key Parsing in LibiGel development (the gel testosterone) program in Endocrine Society 90-e Annual Meeting in San Francisco inn the Centre Moscone in Sunday, 15 June, 2008. The Announcement named ” Cardiovascular And affections Safe thought Libigel In Woman according to Sexual pharmacy pill Disorder of the aspire after Hypoactive (HSDD): Project of the Analysis And Descriptions of the Endpoints,” - co-authored investigator and consultant in University Connecticut School Medicine, Consultants of the Berry, and M.D. The Cancerous Centre Anderson.

The Conference of the news will is organized in Sunday, 15 June, 2008, prep which reporters invited to consider the announcement and discuss LibiGel and described analysis with Dr. Snabes.

BioSante CONDUCTS the safe analysis, in post-woman menopausal with hypoactive sexual health disorder of the desire (HSDD), upon the body request USA. Food and Administration Medicine. The Request - inn accordance with call to more safe disposed from Endocrine Society, medical society two professions, which is convergent in endocrine and metabolic disease.

Dr. Snabes noted importance this preceding instal the analysis. “This clinical test to study the long-term effects testosterone in post-woman menopausal, can be one of first big, cardiovascular operated events, studies pre- approvals were undertaken inn the absence of clear safe signal.”

BioSante EXPECTS that enrolled and is tested aproximately three thousandth posts-womans menopausal between age fifty and cardinal and, which has at least once one cardiovascular factor of the expose to danger. The pharmacy online Primary safe result towards this test - every effect of the processing in incidence heartily when it happened, including cardiovascular bound death, pith attack, and blow. Incidence invasive breast cancer is a primary safe endpoint co-, and investigators decision also observe the accommodative breast breast cancer of the masses and non-invasives. The Patients will are evaluated for hairiness, acne, and speech or reactions of the skin, while far as blood testosterone is justified during each visit of the analysis.

HSDD is CHARACTERIZED low libido and the general defect of the interest in sex. If safe endpoints counter and approves the healing art, LibiGel will become triumph authorized processing specified also in behalf of HSDD in menopausal woman. BioSante EXPECTS the approval certain time during 2010 or 2011.

The Feminine sexual dysfunction can arise right of many reasons, including problems relations, use the pharmaceuticalses of the prescription, disease, or chemical imbalances. HSDD ADDRESSES successfully and luckily with testosterone for many years though and too date not approved for this use. In terminated analysis Phase II LibiGel direct excellent safety and efficiency. However, recently became selfish cardiovascular and cancerous risk spring broad prestige medicine, amongst him potential therapy for FSD. The Safe analysis of the Phase III is witting to confirm long-term safety LibiGel’s.

The Operated analysis studies the effect LibiGel in post-woman drugstore online menopausal in dose 300 micrograms per diem terminated twelve months. BioSante is SPECIFICALLY focused in heartily event and incidence breast cancer. After twelve plans of the months BioSante to apply for have a preference for through New Application Medicine (NDA). requires BioSante to follow the group of the analysis during additional fourty-eight months, after helpfulness NDA and potential approval two compare mate the loving event and withstand cancer between group of the processing and corresponding to group of the womans, who influence the gel

LibiGel - a gel 1% testosterone that woman enclose as soon as day, in there upper lever. Measured pea volume helium carries end skin quickly, from where he delivers the stubborn dose testosterone on blood.

Though testosterone thought-out as male hormone, he is also unconcealed in number on level approaching with their age. The Researchers believe that testosterone will justify, That which fall prep crescendo of the age, can control the feminine sexual desire. For instance, woman in her has about blood testosterone Being of the kind which woman in hits twenty.

Incidence HSDD also increases since age and after determined surgical procedures. Aproximately 14% premenopausal womans between age twenty and fourty-nine qualified HSDD, inn contrast with 26% womans, online pharmacy tablet who surgical have deleted their ovaries. Similarly, incidence HSDD grows before 9% for “naturally” menopausal womans. LibiGel be INTENDED to revive the level testosterone in post-womans menopausal onward level, what one. are considered normal to support sound libido.

The Results of the Analysis, which conclude the above-mentioned safe information finally must lie to put the safe enxiety for processing testosterone in woman and lead too approval of the first safe, operator processing was specifically indicated for HSDD in menopausal woman.